Biblio

16 resultats trouvés
Filtres: Mot-clé is sarcoma  [Clear All Filters]
A
Ray-Coquard I, Hatcher H, Bompas E, Casado A, Westermann A, Isambert N, Casali PGiovanni, Pratap S, Stark D, Valverde C et al..  2020.  A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin +/- ifosfamide following surgery or in metastatic first line treatment (EORT. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 30:1633-1637.
B
Chaigneau L, Patrikidou A, Ray-Coquard I, Valentin T, Linassier C, Bay JOlivier, Zabotto LMoureau, Bompas E, Piperno-Neumann S, Penel N et al..  2018.  Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO). ONCOLOGIST. 23:948-955.
C
Marec-Berard P., Aho S., Berger C., Plantaz D., Aho-Glele L.S, Ducimetiere F., Duclos A., Fontaniere B., Collard O., Blay J.Y et al..  2020.  Clinical management of adolescents and young adults suffering from sarcoma in the French Rhone-Alpes region: A prospective exhaustive cohort with 10 years follow up. EJSO. 46:1301-1309.
E
Falk A.T, Moureau-Zabotto L., Ouali M., Penel N., Italiano A., Bay J.-O, Olivier T., Sunyach M.-P, Boudou-Roquette P., Salas S. et al..  2015.  Effect on Survival of Local Ablative Treatment of Metastases from Sarcomas: A Study of the French Sarcoma Group. CLINICAL ONCOLOGY. 27:48-55.
Khalifa J., Ouali M., Chaltiel L., Le Guellec S., Le Cesne A., Blay J-Y, Cousin P., Chaigneau L., Bompas E., Piperno-Neumann S. et al..  2015.  Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group. BMC CANCER. 15:700.
G
Bellera C.A, Penel N., Ouali M., Bonvalot S., Casali P.G, Nielsen O.S, Delannes M., Litiere S., Bonnetain F., Dabakuyo T.S et al..  2015.  Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). ANNALS OF ONCOLOGY. 26:865-872.
I
Rangan L, Galaine J, Boidot R, Hamieh M, Dosset M, Francoual J, Beziaud L, Pallandre J-R, Joseph ELauret Mar, Asgarova A et al..  2017.  Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A*0201/DRB1*0101 transgenic mice. ONCOTARGET. 8:48959-48971.
Blay J-Y, Soibinet P., Penel N., Bompas E., Duffaud F., Stoeckle E., Mir O., Adam J., Chevreau C., Bonvalot S. et al..  2017.  Improved survival using specialized multidisciplinary board in sarcoma patients. ANNALS OF ONCOLOGY. 28:2852-2859.
Amadeo B, Penel N, Coindre J-M, Ray-Coquard I, Ligier K, Delafosse P, Bouvier A-M, Plouvier S, Gallet J, Lacourt A et al..  2020.  Incidence and time trends of sarcoma (2000-2013): results from the French network of cancer registries (FRANCIM). BMC CANCER. 20:190.
M
Valentin T., Le Cesne A., Ray-Coquard I., Italiano A., Decanter G., Bompas E., Isambert N., Thariat J., Linassier C., Bertucci F. et al..  2016.  Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO). EUROPEAN JOURNAL OF CANCER. 56:77-84.
P
Isambert N, Ray-Coquard I, Italiano A, Rios M, Kerbrat P, Gauthier M, Blouet A, Chaigneau L, Duffaud F, Piperno-Neumann S et al..  2014.  Primary cardiac sarcomas: A retrospective study of the French Sarcoma Group. EUROPEAN JOURNAL OF CANCER. 50:128-136.
R
Thariat J., Clement-Cohmou K., Vogin G., Beckendorf V., Ducassou A., Ali A.M, Salas S., Saada E., Thyss A., Lapeyre M. et al..  2014.  Radiation therapy of cardiac sarcomas. CANCER RADIOTHERAPIE. 18:125-131.
S
Cerda T., Martin E., Truc G., Crehange G., Maingon P..  2017.  Safety and efficacy of intensity-modulated radiotherapy in the management of spermatic cord sarcoma. CANCER RADIOTHERAPIE. 21:16-20.
Blay J.Y, Honore C., Stoeckle E., Meeus P., Jafari M., Gouin F., Anract P., Ferron G., Rochwerger A., Ropars M. et al..  2019.  Surgery in reference centers improves survival of sarcoma patients: a nationwide study. ANNALS OF ONCOLOGY. 30:1143-1153.
T
Eberst L, Cropet C, Le Cesne A, Pautier P, Penel N, Adenis A, Chevreau C, Bay J-O, Collard O, Cupissol D et al..  2014.  The off-label use of targeted therapies in sarcomas: the OUTC'S program. BMC CANCER. 14:870.
Le Cesne A, Ray-Coquard I, Duffaud F, Chevreau C, Penel N, Nguyen BBui, Piperno-Neumann S, Delcambre C, Rios M, Chaigneau L et al..  2015.  Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group. EUROPEAN JOURNAL OF CANCER. 51:742-750.